First Time Loading...

XOMA Corp
NASDAQ:XOMA

Watchlist Manager
XOMA Corp Logo
XOMA Corp
NASDAQ:XOMA
Watchlist
Price: 25.56 USD 3.94% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. [ Read More ]

The intrinsic value of one XOMA stock under the Base Case scenario is 16.46 USD. Compared to the current market price of 25.56 USD, XOMA Corp is Overvalued by 36%.

Key Points:
XOMA Intrinsic Value
Base Case
16.46 USD
Overvaluation 36%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
XOMA Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling XOMA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
XOMA Corp

Provide an overview of the primary business activities
of XOMA Corp.

What unique competitive advantages
does XOMA Corp hold over its rivals?

What risks and challenges
does XOMA Corp face in the near future?

Has there been any significant insider trading activity
in XOMA Corp recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for XOMA Corp.

Provide P/S
for XOMA Corp.

Provide P/E
for XOMA Corp.

Provide P/OCF
for XOMA Corp.

Provide P/FCFE
for XOMA Corp.

Provide P/B
for XOMA Corp.

Provide EV/S
for XOMA Corp.

Provide EV/GP
for XOMA Corp.

Provide EV/EBITDA
for XOMA Corp.

Provide EV/EBIT
for XOMA Corp.

Provide EV/OCF
for XOMA Corp.

Provide EV/FCFF
for XOMA Corp.

Provide EV/IC
for XOMA Corp.

Show me price targets
for XOMA Corp made by professional analysts.

What are the Revenue projections
for XOMA Corp?

How accurate were the past Revenue estimates
for XOMA Corp?

What are the Net Income projections
for XOMA Corp?

How accurate were the past Net Income estimates
for XOMA Corp?

What are the EPS projections
for XOMA Corp?

How accurate were the past EPS estimates
for XOMA Corp?

What are the EBIT projections
for XOMA Corp?

How accurate were the past EBIT estimates
for XOMA Corp?

Compare the revenue forecasts
for XOMA Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of XOMA Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of XOMA Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of XOMA Corp compared to its peers.

Compare the P/E ratios
of XOMA Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing XOMA Corp with its peers.

Analyze the financial leverage
of XOMA Corp compared to its main competitors.

Show all profitability ratios
for XOMA Corp.

Provide ROE
for XOMA Corp.

Provide ROA
for XOMA Corp.

Provide ROIC
for XOMA Corp.

Provide ROCE
for XOMA Corp.

Provide Gross Margin
for XOMA Corp.

Provide Operating Margin
for XOMA Corp.

Provide Net Margin
for XOMA Corp.

Provide FCF Margin
for XOMA Corp.

Show all solvency ratios
for XOMA Corp.

Provide D/E Ratio
for XOMA Corp.

Provide D/A Ratio
for XOMA Corp.

Provide Interest Coverage Ratio
for XOMA Corp.

Provide Altman Z-Score Ratio
for XOMA Corp.

Provide Quick Ratio
for XOMA Corp.

Provide Current Ratio
for XOMA Corp.

Provide Cash Ratio
for XOMA Corp.

What is the historical Revenue growth
over the last 5 years for XOMA Corp?

What is the historical Net Income growth
over the last 5 years for XOMA Corp?

What is the current Free Cash Flow
of XOMA Corp?

Financials

Balance Sheet Decomposition
XOMA Corp

Current Assets 169.3m
Cash & Short-Term Investments 153.5m
Receivables 15.2m
Other Current Assets 643k
Non-Current Assets 65m
PP&E 403k
Other Non-Current Assets 64.6m
Current Liabilities 19.5m
Accounts Payable 653k
Accrued Liabilities 2.8m
Other Current Liabilities 16m
Non-Current Liabilities 126.1m
Long-Term Debt 118.5m
Other Non-Current Liabilities 7.6m
Efficiency

Earnings Waterfall
XOMA Corp

Revenue
4.8m USD
Operating Expenses
-30.8m USD
Operating Income
-26m USD
Other Expenses
-20.3m USD
Net Income
-46.3m USD

Free Cash Flow Analysis
XOMA Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

XOMA Profitability Score
Profitability Due Diligence

XOMA Corp's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive 3-Year Average ROIC
Negative 1-Year Revenue Growth
Declining ROE
23/100
Profitability
Score

XOMA Corp's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

XOMA Solvency Score
Solvency Due Diligence

XOMA Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
50/100
Solvency
Score

XOMA Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XOMA Price Targets Summary
XOMA Corp

Wall Street analysts forecast XOMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XOMA is 75.48 USD with a low forecast of 74.74 USD and a high forecast of 77.7 USD.

Lowest
Price Target
74.74 USD
192% Upside
Average
Price Target
75.48 USD
195% Upside
Highest
Price Target
77.7 USD
204% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

XOMA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

XOMA Price
XOMA Corp

1M 1M
+4%
6M 6M
+50%
1Y 1Y
+37%
3Y 3Y
-28%
5Y 5Y
+106%
10Y 10Y
-70%
Annual Price Range
25.56
52w Low
13.82
52w High
26.35
Price Metrics
Average Annual Return 27.36%
Standard Deviation of Annual Returns 74.38%
Max Drawdown -70%
Shares Statistics
Market Capitalization 293.8m USD
Shares Outstanding 11 635 000
Percentage of Shares Shorted 3.45%

XOMA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

XOMA Corp Logo
XOMA Corp

Country

United States of America

Industry

Biotechnology

Market Cap

293.8m USD

Dividend Yield

0%

Description

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. The company is headquartered in Emeryville, California and currently employs 12 full-time employees. The firm's drug royalty aggregator business is focused on early to mid-stage clinical assets primarily in Phase I and II. XOMA acquires pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The firm's portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. The firm's royalty-aggregator business includes acquiring additional licenses to programs with third-party funding and has more than 70 assets. XOMA royalty portfolio includes NIS793, anti-transforming growth factor-beta (TGFb) antibody program; gevokizumab (VPM087); mezagitamab (TAK-079), iscalimab (CFZ533), and MK-4830.

Contact

CALIFORNIA
Emeryville
2200 Powell St Ste 310
+15102047239.0
https://www.xoma.com/

IPO

1986-06-06

Employees

12

Officers

CEO & Director
Mr. Owen P. Hughes Jr.
Senior VP of Finance & CFO
Mr. Thomas M. Burns
Chief Investment Officer
Mr. Brad Sitko

See Also

Discover More
What is the Intrinsic Value of one XOMA stock?

The intrinsic value of one XOMA stock under the Base Case scenario is 16.46 USD.

Is XOMA stock undervalued or overvalued?

Compared to the current market price of 25.56 USD, XOMA Corp is Overvalued by 36%.